These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33007583)

  • 41. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST; Wong EK
    Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Trials; 2015 Aug; 16():355. PubMed ID: 26272324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19.
    Dagher H; Chaftari AM; Mulanovich P; Jiang Y; Hachem R; Malek AE; Borjan J; Viola GM; Raad I
    Elife; 2022 Dec; 11():. PubMed ID: 36541589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia.
    Uranga A; Artaraz A; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; García JA; Camino J; España PP
    BMC Pulm Med; 2020 Oct; 20(1):261. PubMed ID: 33028293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of procalcitonin-guided therapy for hospitalized community-acquired pneumonia on reducing antibiotic consumption and costs in Japan.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    J Infect Chemother; 2017 Mar; 23(3):142-147. PubMed ID: 28024740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of the respiratory viral panel as an antimicrobial stewardship tool.
    Covert K; Bashore E; Edds M; Lewis PO
    J Clin Pharm Ther; 2021 Apr; 46(2):277-285. PubMed ID: 33277930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of a guideline on management of children hospitalized with community-acquired pneumonia.
    Newman RE; Hedican EB; Herigon JC; Williams DD; Williams AR; Newland JG
    Pediatrics; 2012 Mar; 129(3):e597-604. PubMed ID: 22351891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.
    Ito A; Ito I; Inoue D; Marumo S; Ueda T; Nakagawa H; Taki M; Nakagawa A; Tatsumi S; Nishimura T; Shiota T; Ishida T
    Int J Infect Dis; 2020 Mar; 92():228-233. PubMed ID: 31981766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Procalcitonin and Antibiotics in Children With Community-Acquired Pneumonia.
    Sekmen M; Johnson J; Zhu Y; Sartori LF; Grijalva CG; Stassun J; Arnold DH; Ampofo K; Robison J; Gesteland PH; Pavia AT; Williams DJ
    Hosp Pediatr; 2022 Apr; 12(4):384-391. PubMed ID: 35362055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia.
    Wang W; Zhu Y; Yin L; Deng Y; Chu G; Liu S
    Mol Cell Biochem; 2021 Jan; 476(1):261-267. PubMed ID: 32990893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia.
    Blatt SP; Yultyev A; Huang M; Friedstrom S; Steinbrunner J
    Am J Infect Control; 2017 Dec; 45(12):1396-1398. PubMed ID: 28865937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
    Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
    Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combining Procalcitonin and Rapid Multiplex Respiratory Virus Testing for Antibiotic Stewardship in Older Adult Patients With Severe Acute Respiratory Infection.
    Lee CC; Chang JC; Mao XW; Hsu WT; Chen SY; Chen YC; How CK
    J Am Med Dir Assoc; 2020 Jan; 21(1):62-67. PubMed ID: 31791902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial.
    Masiá M; Padilla S; Ortiz de la Tabla V; González M; Bas C; Gutiérrez F
    PLoS One; 2017; 12(4):e0175634. PubMed ID: 28426811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of procalcitonin in diagnosis of community acquired pneumonia in Children.
    Ratageri VH; Panigatti P; Mukherjee A; Das RR; Goyal JP; Bhat JI; Vyas B; Lodha R; Singhal D; Kumar P; Singh K; Mahapatro S; Charoo BA; Kabra SK; Jat KR
    BMC Pediatr; 2022 Apr; 22(1):217. PubMed ID: 35443627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital.
    Kook JL; Chao SR; Le J; Robinson PA
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):424-6. PubMed ID: 22418643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of a Personalized Audit and Feedback Intervention on Antibiotic Prescribing Practices for Outpatient Pediatric Community-Acquired Pneumonia.
    Diaz MCG; Handy LK; Crutchfield JH; Cadilla A; Hossain J; Werk LN
    Clin Pediatr (Phila); 2020 Oct; 59(11):988-994. PubMed ID: 32486840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.